100 related articles for article (PubMed ID: 14608894)
1. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer.
Rudlowski C; Becker AJ; Schroder W; Rath W; Büttner R; Moser M
Am J Clin Pathol; 2003 Nov; 120(5):691-8. PubMed ID: 14608894
[TBL] [Abstract][Full Text] [Related]
2. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer.
Rudlowski C; Moser M; Becker AJ; Rath W; Buttner R; Schroder W; Schurmann A
Oncology; 2004; 66(5):404-10. PubMed ID: 15331928
[TBL] [Abstract][Full Text] [Related]
3. Expression of facilitative glucose transporters in gastric tumors.
Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
[TBL] [Abstract][Full Text] [Related]
4. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
5. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis.
Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827
[TBL] [Abstract][Full Text] [Related]
6. Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
Branca M; Ciotti M; Santini D; Bonito LD; Benedetto A; Giorgi C; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K;
Am J Clin Pathol; 2004 Dec; 122(6):902-11. PubMed ID: 15539382
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
8. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Younes M; Lechago LV; Lechago J
Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
11. Gene identification by cDNA arrays in HPV-positive cervical cancer.
Vázquez-Ortíz G; Ciudad CJ; Piña P; Vazquez K; Hidalgo A; Alatorre B; Garcia JA; Salamanca F; Peralta-Rodriguez R; Rangel A; Salcedo M
Arch Med Res; 2005; 36(5):448-58. PubMed ID: 16099320
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
14. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
15. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
[TBL] [Abstract][Full Text] [Related]
16. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778
[TBL] [Abstract][Full Text] [Related]
17. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R
Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885
[TBL] [Abstract][Full Text] [Related]
18. Expression of glucose transporter 1 in human endometrial and decidual tissue.
Strowitzki T; Capp E; von Wolff M; Müller-Höcker J
Gynecol Endocrinol; 2001 Jun; 15(3):219-24. PubMed ID: 11447734
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of glucose transporters and its regulation by glucose in mesothelial cells.
Lu C; Ye R; Yang Q; Yang X; Li H; Li Y
Chin Med J (Engl); 2001 May; 114(5):477-80. PubMed ID: 11780407
[TBL] [Abstract][Full Text] [Related]
20. Distribution of the glucose transporters in human brain tumors.
Nishioka T; Oda Y; Seino Y; Yamamoto T; Inagaki N; Yano H; Imura H; Shigemoto R; Kikuchi H
Cancer Res; 1992 Jul; 52(14):3972-9. PubMed ID: 1617673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
